Keyphrases
Neurocognitive Function
100%
Pediatric Brain Tumor
62%
Traumatic Brain Injury
41%
Pediatric Traumatic Brain Injury
41%
Acute Lymphoblastic Leukemia
41%
Risk Factors
40%
Survivors
38%
Clinical Trials
35%
Processing Speed
33%
Tumor Location
25%
Neuropsychological Assessment
24%
Childhood Acute Lymphoblastic Leukemia
24%
Cognitive Impairment
24%
Learning Problems
24%
Childhood Cancer
24%
Parent Ratings
24%
Multisensory Integration
20%
Measuring Quality
20%
Postoperative Cerebellar mutism Syndrome
20%
Neuropathic Pain
20%
Transitional Care
20%
Sickle Cell Disease
20%
PFDR
20%
Linguistic Scale
20%
Cultural Groups
20%
Longitudinal Association
20%
Anesthesia
20%
Collaborative Translation
20%
Pediatric Medulloblastoma
20%
Anesthesia Exposure
20%
Natural Intervention
20%
Artificial Intervention
20%
Longitudinal Trajectories
20%
Consensus Framework
20%
Adult Care
20%
Cognitive Performance
20%
Perioperative Risk Factors
20%
Feedback Behavior
20%
Feedback Learning
20%
Conductive Phase
20%
Behavior Problems
20%
Brain Tumor Patients
20%
Preadolescent children
20%
Quality of Survival
20%
International Working Groups
20%
International Consensus
20%
Radiotherapy-induced
20%
Chemotherapy
20%
Older Adults
20%
Sleep Problems
20%
Posttraumatic Stress Symptoms
20%
Adaptation
20%
Medulloblastoma
20%
Pediatric Low-grade Glioma
20%
Cognitive Scale
20%
Consensus Statement
20%
Phase III Clinical Trial
20%
White Matter
20%
Working Diagnosis
19%
California Verbal Learning Test
19%
Moderate to Severe Traumatic Brain Injury
18%
Healthcare Professionals
18%
Attention Learning
17%
Neurocognitive Assessment
16%
Brain Tumor
15%
Neurocognitive Deficits
14%
Linguistic Groups
13%
Visual Stimuli
13%
Cognitive Recovery
13%
Spanish Translation
13%
International Consultation
13%
Attention Problems
13%
Neurocognitive Profile
13%
Psychologists
13%
Supratentorial
13%
Opioids
12%
Quality of Life
12%
Tumor
11%
Mild Traumatic Brain Injury (mTBI)
11%
Learning Slope
11%
Psychosocial Outcomes
11%
Sustained Attention
11%
Memory Performance
11%
Drift Rate
10%
Set-shifting
10%
Transition Outcomes
10%
Average Risk
10%
Anesthesia Duration
10%
Neurocognitive Decline
10%
Female Sex
10%
Age at Diagnosis
9%
Clinically Significant
9%
Neurocognitive Testing
8%
End of Therapy
8%
Gabapentin
8%
Generalized Learning
8%
Externalizing Behavior
8%
Pediatric
7%
Treatment-related
7%
Environmental Factors
7%
Medicine and Dentistry
Pediatric Brain Tumor
41%
Neoplasm
38%
Clinical Trial
30%
Pediatrics
25%
Childhood Cancer
23%
Adolescence
23%
Neuropathic Pain
20%
Ganglioglioma
20%
Mutism
20%
Translating (Language)
20%
Acute Lymphoblastic Leukemia
20%
Medulloblastoma
20%
Intracranial Tumor
20%
Opiate
12%
California Verbal Learning Test
12%
Visual Stimulation
10%
Clinician
10%
Gabapentin
8%
Intelligence Quotient
7%
Quality of Life
7%
Group Process
5%
Excessive Daytime Sleepiness
5%
Patient Social Context
5%
Adverse Outcome
5%
Patient Population
5%
Pediatric Rehabilitation
5%
Psychological Well-Being
5%
Body Mass Index
5%
Cancer Diagnosis
5%
Physical Well-Being
5%
Intervention Study
5%
Prevalence
5%
Environmental Factor
5%